<DOC>
	<DOCNO>NCT00314990</DOCNO>
	<brief_summary>The VITRO ( Vitamins Thrombosis ) study investigated effect homocysteine lower daily supplementation B-vitamins risk reduction deep-vein thrombosis pulmonary embolism . Patients 20 80 year old first objectively confirm proximal deep-vein thrombosis pulmonary embolism absence major risk factor homocysteine concentration 75th percentile reference group ask participate ( hyperhomocysteinemic group ) . A similar study conduct random sample patient homocysteine 75th percentile reference group ( normohomocysteinemic group ) . After informed consent patient randomize daily multivitamin supplementation ( 5 mg folic acid , 50 mg pyridoxine 0.4 mg cyanocobalamin ) placebo follow 2.5 year . End-points objectively diagnosed recurrent deep-vein thrombosis pulmonary embolism .</brief_summary>
	<brief_title>VITRO-Trial . B Vitamins Secondary Prevention Venous Thrombosis</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin B 12</mesh_term>
	<mesh_term>Hydroxocobalamin</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Pyridoxine</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<criteria>objectively confirm proximal deepvein thrombosis pulmonary embolism idiopathic thrombosis ( i.e . absence major risk factor ( major surgery , know malignant disease , pregnancy puerperium immobility three week ) age 20 80 year obligatory use vitamin B</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2006</verification_date>
	<keyword>Venous thrombosis</keyword>
	<keyword>Deep-vein thrombosis</keyword>
	<keyword>Pulmonary embolism</keyword>
	<keyword>Homocysteine</keyword>
	<keyword>B-vitamins</keyword>
	<keyword>Folate</keyword>
	<keyword>Vitamin B12</keyword>
	<keyword>Vitamin B6</keyword>
</DOC>